Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
Clinical trial NCT01871558 · COMPLETED
Trial details
- NCT number
- NCT01871558
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-02-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.